NCT07405268
Evaluation of the Effects of Levodopa-Benserazide Drug Combination on Periodontal Status in Patients With Parkinson's Disease
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 15 words Show 6 more changesShow less
- Trial completed
- Primary completion date changed from estimate of Oct 10, 2026 to Oct 13, 2026
- Study completion date changed from estimate of Nov 10, 2026 to Nov 13, 2026
- Study description revised
- Site details revised
- Publications: details revised at 3 of 3 entries
- Minor Primary completion pushed from Aug 10, 2026 to Oct 10, 2026v3
- Minor Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Study sites: 0 to 1
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Salivary Inflammatory Cytokine
Timeframe: Day 1
Salivary Oxidative Stress Levels
Timeframe: Day 1
Secondary (1)
Clinical Periodontal Parameters
Arms and interventions
Parkinson's - Periodontitis
Patients diagnosed with Parkinson's Disease who also have Periodontitis.
Parkinson's - Healthy
Patients diagnosed with Parkinson's Disease who are periodontally healthy.
Control - Periodontitis
Systemically healthy participants (non-Parkinson) who have Periodontitis.
Control - Healthy
Systemically and periodontally healthy participants.
Sites
1 site in 1 country
- Sağlık Bilimleri Üniversitesi Gülhane Diş Hekimliği FakültesiAnkara, Ankara, Turkey (Türkiye)